Find policies, billing codes, payers, states, and providers
Loading...
Find policies, billing codes, payers, states, and providers
CPT 55705: Prostate Tissue Sampling, Non‑Imaging Guided
CPT-55706-TEMPLATE-GUIDED-TRANSPERINEAL-PROSTATE-SATURATION-BIOPSYCPT 55706: Template-Guided Saturation Biopsy of Prostate
CPT-55707-TRANSRECTAL-ULTRASOUND-GUIDED-PROSTATE-BIOPSY-SEXTANTCPT 55707: Transrectal Ultrasound-Guided Prostate Biopsy, Sextant and Targeted
CPT-55708-PROSTATE-BIOPSY-TRANSRECTAL-US-FUSION-TARGETED-SEXTANTCPT 55708: Transrectal Ultrasound–Guided Prostate Biopsy with MRI Fusion
CPT-55709-TRANSPERINEAL-ULTRASOUND-GUIDED-PROSTATE-BIOPSYCPT 55709: Perineal Ultrasound-Guided Prostate Biopsy
CPT-55710-TRANSPERINEAL-ULTRASOUND-FUSION-PROSTATE-BIOPSYCPT 55710: Transperineal Ultrasound‑Guided Sextant and Fusion Prostate Biopsy
CPT-55711-MRI-ULTRASOUND-FUSION-TARGETED-PROSTATE-BIOPSY-FIRST-LESIONCPT 55711: Transrectal MRI–Ultrasound Fusion Targeted Prostate Biopsy, First Lesion
CPT-55712-TRANSPERINEAL-MRI-ULTRASOUND-FUSION-BIOPSY-SINGLE-LESIONCPT 55712: Transperineal MRI–Ultrasound Fusion Targeted Prostate Biopsy, First Lesion
CPT-55713-IMAGE-GUIDED-PROSTATE-BIOPSY-SEXTANT-AND-TARGETED-LESIONCPT 55713: Image-Guided Prostate Biopsy, Sextant and Targeted Sampling
CPT-55714-IMAGE-GUIDED-TARGETED-PROSTATE-BIOPSY-CT-MRICPT 55714: CT or MRI-Guided Targeted Prostate Biopsy
Showing 1–10 of 13
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.